![Mary Schubauer-Berigan: Exceptional contributions from our 30 Working Group members who spent more than one year thoroughly evaluating the carcinogenicity of PFOA and PFOS](https://oncodaily.com/pub/uploads/2023/10/1685985196852-fotor-2023100814135-e1701801058955-1280x898.jpg)
Photo taken from Mary Schubauer-Berigan/LinkedIn
Dec 6, 2023, 16:15
Mary Schubauer-Berigan: Exceptional contributions from our 30 Working Group members who spent more than one year thoroughly evaluating the carcinogenicity of PFOA and PFOS
Mary Schubauer-Berigan, Head of the Monographs Programme at the International Agency for Research on Cancer, shared IARC’s post on X/Twitter adding:
“Exceptional contributions from our 30 Working Group members who spent more than 1 year thoroughly evaluating the carcinogenicity of PFOA and PFOS.”
Quoting IARC‘s post below:
“The IARC Monographs programme has evaluated the carcinogenicity of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and classified PFOA as carcinogenic to humans (Group 1) and PFOS as possibly carcinogenic to humans (Group 2B)”
Sources: Mary Schubauer-Berigan/X and IARC/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023